secwatch.observer — SEC 8-K summary
======================================

Issuer:     eFFECTOR Therapeutics, Inc. (—)
CIK:        0001828522
Form:       8-K
Filed at:   2024-05-17T23:59:59+00:00
Accession:  0001193125-24-141847
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

eFFECTOR receives Nasdaq notice for MVLS below $35M; 180-day cure period until Nov 12, 2024
--------------------------------------------------------------------------------

- Notice dated May 16, 2024 for failure to meet $35M minimum value of listed securities for 30 consecutive business days.
- Company has until November 12, 2024 to regain compliance by closing at $35M+ for 10 consecutive business days.
- If non-compliant, Nasdaq may delist common stock (EFTR) and warrants (EFTRW).
- Alternative compliance standard: maintain minimum stockholders' equity of $2.5M under Rule 5550(b)(1).
- Management evaluating options but cannot assure regaining compliance or continued listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828522/000119312524141847/0001193125-24-141847-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828522/000119312524141847/d817743d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-141847

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer